Загрузка...

Lilly–Innovent Partnership, Takeda’s AI Strategy, J&J Recall

China-sourced drug development, AI-enabled discovery, FDA telehealth extension, and Krystal Biotech RMAT.

Видео Lilly–Innovent Partnership, Takeda’s AI Strategy, J&J Recall канала BioMed Nexus
Комментарии отсутствуют
Зарегистрируйтесь или войдите с
Информация о видео
25 февраля 2026 г. 10:29:34
00:07:20
BioMed Nexus
Правообладателям
Жалоба на материал Недопустимый материал Нарушение авторских прав
Комментарии
Поделиться
Другие видео канала

The Wegovy Pill Just Doubled Expectations: Why Novo Nordisk is Winning the Weight Loss WarThe Wegovy Pill Just Doubled Expectations: Why Novo Nordisk is Winning the Weight Loss War

Biotech Market Outlook Q1 2026: Top 7 Picks & Capital Rotation StrategyBiotech Market Outlook Q1 2026: Top 7 Picks & Capital Rotation Strategy

The Iran War Is Now Hitting Pharma Supply Chains DirectlyThe Iran War Is Now Hitting Pharma Supply Chains Directly

Lilly's Next Obesity Drug Just Matched Bariatric Surgery in a Phase 3 TrialLilly's Next Obesity Drug Just Matched Bariatric Surgery in a Phase 3 Trial

Top 6 Biotech Stocks to Watch THIS WEEK (JPM 2026 Insider Playbook)Top 6 Biotech Stocks to Watch THIS WEEK (JPM 2026 Insider Playbook)

20 Biotech Startups to Watch in 2026: AI, Gene Editing & Obesity [The Full List]20 Biotech Startups to Watch in 2026: AI, Gene Editing & Obesity [The Full List]

GSK’s $950M PAH Bet: 35Pharma Deal Signals Activin RaceGSK’s $950M PAH Bet: 35Pharma Deal Signals Activin Race

Q1 2026 Biotech Outlook AI Deep Dive & Stock AnalysisQ1 2026 Biotech Outlook AI Deep Dive & Stock Analysis

UNH Crashes 20%: The End of Managed Care’s Golden Era? (+ Intellia & Sarepta Wins)UNH Crashes 20%: The End of Managed Care’s Golden Era? (+ Intellia & Sarepta Wins)

Future of Medicine 2026: Full Breakdown of 20 Biotech Startups (AI, Obesity, CRISPR)Future of Medicine 2026: Full Breakdown of 20 Biotech Startups (AI, Obesity, CRISPR)

The End of Cancer? The $50 Blood Test & The Great Medical ShiftThe End of Cancer? The $50 Blood Test & The Great Medical Shift

23% Weight Loss Data Revealed! Is Kailera (KAI-9531) the New Wegovy Killer?23% Weight Loss Data Revealed! Is Kailera (KAI-9531) the New Wegovy Killer?

Lilly Makes Its Fifth Acquisition of 2026 — That's Nearly $20B in Deals in Three MonthsLilly Makes Its Fifth Acquisition of 2026 — That's Nearly $20B in Deals in Three Months

FDA Signals Shift to Single-Trial Standard | Insmed Guides to $1B | Madrigal Nears BlockbusterFDA Signals Shift to Single-Trial Standard | Insmed Guides to $1B | Madrigal Nears Blockbuster

PhRMA's Longest-Serving CEO Is Stepping Down • FDA Proposes a Faster Path to Phase 1PhRMA's Longest-Serving CEO Is Stepping Down • FDA Proposes a Faster Path to Phase 1

Four FDA Approvals in One Week • Novartis Drops $3B • The Obesity War Just Got a New FrontFour FDA Approvals in One Week • Novartis Drops $3B • The Obesity War Just Got a New Front

BridgeBio Phase 3 Win • FDA HRT Label Shift • Universal Flu TrialBridgeBio Phase 3 Win • FDA HRT Label Shift • Universal Flu Trial

FDA Approves Bysanti | The Single-Trial Era BeginsFDA Approves Bysanti | The Single-Trial Era Begins

Japan Approves First iPS Therapies • Xenon’s Record Epilepsy Data • FDA Eases Biosimilar PathJapan Approves First iPS Therapies • Xenon’s Record Epilepsy Data • FDA Eases Biosimilar Path

Pfizer's Lyme Vaccine Misses But Files Anyway • Apogee's Twice-a-Year Eczema ShotPfizer's Lyme Vaccine Misses But Files Anyway • Apogee's Twice-a-Year Eczema Shot

Яндекс.Метрика
© 2008-2026 «Информационно-развлекательный портал города Верхняя Салда»
salda.ws@mail.ru salda_ws Контакты Карта портала Сообщить об ошибке Соглашения Пользовательское соглашение Соглашение о конфиденциальности Согласие на обработку персональных данных Информация для правообладателей Об использовании Cookies
Все заметки Новая заметка Страницу в заметки
Страницу в закладки Мои закладки
На информационно-развлекательном портале SALDA.WS применяются cookie-файлы. Нажимая кнопку Принять, вы подтверждаете свое согласие на их использование.
О CookiesНапомнить позжеПринять